Iankov ID - Search Results

1

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H . pylori immunostimulatory bacterial transgene.

Viker KB, Steele MB, Iankov ID, Concilio SC, Ammayappan A, Bolon B, Jenks NJ, Goetz MP, Panagioti E, Federspiel MJ, Liu MC, Peng KW, Galanis E. Viker KB, et al. Among authors: iankov id. Mol Ther Methods Clin Dev. 2022 Jul 31;26:532-546. doi: 10.1016/j.omtm.2022.07.014. eCollection 2022 Sep 8. Mol Ther Methods Clin Dev. 2022. PMID: 36092362 Free PMC article.

2

Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.

Iankov ID, Pandey M, Harvey M, Griesmann GE, Federspiel MJ, Russell SJ. Iankov ID, et al. J Virol. 2006 Sep;80(17):8530-40. doi: 10.1128/JVI.00593-06. J Virol. 2006. PMID: 16912303 Free PMC article.

3

Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.

Iankov ID, Blechacz B, Liu C, Schmeckpeper JD, Tarara JE, Federspiel MJ, Caplice N, Russell SJ. Iankov ID, et al. Mol Ther. 2007 Jan;15(1):114-22. doi: 10.1038/sj.mt.6300020. Mol Ther. 2007. PMID: 17164782 Free article.

4

Engineering oncolytic measles virus to circumvent the intracellular innate immune response.

Haralambieva I, Iankov I, Hasegawa K, Harvey M, Russell SJ, Peng KW. Haralambieva I, et al. Mol Ther. 2007 Mar;15(3):588-97. doi: 10.1038/sj.mt.6300076. Epub 2007 Jan 16. Mol Ther. 2007. PMID: 17245355 Free PMC article.

5

Oncolytic measles virus strains in the treatment of gliomas.

Allen C, Paraskevakou G, Liu C, Iankov ID, Msaouel P, Zollman P, Myers R, Peng KW, Russell SJ, Galanis E. Allen C, et al. Among authors: iankov id. Expert Opin Biol Ther. 2008 Feb;8(2):213-20. doi: 10.1517/14712598.8.2.213. Expert Opin Biol Ther. 2008. PMID: 18194077 Free PMC article. Review.

6

Heat shock protein inhibitors increase the efficacy of measles virotherapy.

Liu C, Erlichman C, McDonald CJ, Ingle JN, Zollman P, Iankov I, Russell SJ, Galanis E. Liu C, et al. Gene Ther. 2008 Jul;15(14):1024-34. doi: 10.1038/gt.2008.30. Epub 2008 Mar 20. Gene Ther. 2008. PMID: 18356818 Free PMC article.

7

Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity.

Allen C, Paraskevakou G, Iankov I, Giannini C, Schroeder M, Sarkaria J, Schroeder M, Puri RK, Russell SJ, Galanis E. Allen C, et al. Mol Ther. 2008 Sep;16(9):1556-64. doi: 10.1038/mt.2008.152. Epub 2008 Jul 29. Mol Ther. 2008. PMID: 18665158 Free PMC article.

8

Engineered measles virus as a novel oncolytic therapy against prostate cancer.

Msaouel P, Iankov ID, Allen C, Morris JC, von Messling V, Cattaneo R, Koutsilieris M, Russell SJ, Galanis E. Msaouel P, et al. Among authors: iankov id. Prostate. 2009 Jan 1;69(1):82-91. doi: 10.1002/pros.20857. Prostate. 2009. PMID: 18973133 Free PMC article.

9

Converting tumor-specific markers into reporters of oncolytic virus infection.

Iankov ID, Hillestad ML, Dietz AB, Russell SJ, Galanis E. Iankov ID, et al. Mol Ther. 2009 Aug;17(8):1395-403. doi: 10.1038/mt.2009.92. Epub 2009 May 26. Mol Ther. 2009. PMID: 19471250 Free PMC article.

10

Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter.

Msaouel P, Iankov ID, Allen C, Aderca I, Federspiel MJ, Tindall DJ, Morris JC, Koutsilieris M, Russell SJ, Galanis E. Msaouel P, et al. Among authors: iankov id. Mol Ther. 2009 Dec;17(12):2041-8. doi: 10.1038/mt.2009.218. Epub 2009 Sep 22. Mol Ther. 2009. PMID: 19773744 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page